Baxter's Blood-Clotting Patent Survives J&J Challenge
A European appeals panel has rejected an attempt by a subsidiary of Johnson & Johnson to revoke Baxter Healthcare's patent for a treatment that stops bleeding, upholding an amended version of the...To view the full article, register now.
Already a subscriber? Click here to view full article